I have been on Trajenta (pill) for a year. I don't see any specs on this as a treatment for diabetes 2. Too new?
Trajenta was approved for the treatment of type 2 diabetes in May of 2011. It is in a class of drugs called DPP4 inhibitors. DPP4 inhibitors work by inhibiting the breakdown of GLP1 hormones, which are naturally occurring in the body and help make more insulin during and after meals. For people with type 2 diabetes, GLP1 hormone levels are lower than they should be, so the DPP4 inhibitors help increase these naturally occurring GLP1hormone levels. Though DPP4 inhibitors are newer to the antidiabetes drug marketplace, they cause few side effects and are well-tolerated, making them a popular second option after metformin.